Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hypomethylation of TET2 target genes for identifying a curable subgroup of acute myeloid leukemia

Hypomethylation of TET2 target genes for identifying a curable subgroup of acute myeloid leukemia

US Patent 12018330 · Granted Jun 25, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminothiazole compounds and methods using same2023
Bridged bicycloalkyl-substituted aminothiazoles and their methods of use2021
Aminothiazole compounds and methods using same2019
Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer2014
Detection of bladder cancer2013
Methylated CpG island amplification (MCA)2012
Methylated CpG island amplification (MCA)2010
PITX2 polynucleotide, polypeptide and methods of use therefor2008
CACNA1G polynucleotide, polypeptide and methods of use therefor2004